lamictal chewable dispersible tablet 5mg - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

lamictal 50 mg chewable/dispersible tablets

lexon pharmaceuticals (ireland) limited - lamotrigine - chewable/dispersible tablet - 50 milligram(s) - other antiepileptics; lamotrigine

Australia - English - Department of Health (Therapeutic Goods Administration)

lamictal lamotrigine 200 mg dispersible/chewable tablet blister pack

aspen pharmacare australia pty ltd - lamotrigine, quantity: 200 mg - tablet - excipient ingredients: calcium carbonate; hyprolose; aluminium magnesium silicate; sodium starch glycollate; povidone; saccharin sodium; magnesium stearate; flavour - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as ?add-on? therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

lamictal lamotrigine 50 mg dispersible/chewable tablet blister pack

aspen pharmacare australia pty ltd - lamotrigine, quantity: 50 mg - tablet - excipient ingredients: calcium carbonate; hyprolose; aluminium magnesium silicate; sodium starch glycollate; povidone; saccharin sodium; magnesium stearate; flavour - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as add-on therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

lamictal lamotrigine 100 mg dispersible/chewable tablet blister pack

aspen pharmacare australia pty ltd - lamotrigine, quantity: 100 mg - tablet - excipient ingredients: calcium carbonate; hyprolose; aluminium magnesium silicate; sodium starch glycollate; povidone; saccharin sodium; magnesium stearate; flavour - lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. there is extensive experience with lamictal used initially as ?add-on? therapy. the use of lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see clinical trials). lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.

Ireland - English - HPRA (Health Products Regulatory Authority)

lamictal 25mg dispersible/chewable tablets

profind wholesale ltd - lamotrigine - chewable/dispersible tablet - 25 milligram(s) - lamotrigine